Home

Research

Congress highlights

Expert guidance on management of schizophrenia for a better quality of life and independence

Individualized patient management is key to achieving better lifetime quality of life and...

Digital technology in psychosis – it’s no delusion

The application of digital interventions is starting to emerge as part of a rapidly expanding cache...

Alzheimer's Disease

Congress highlights

Latest insights into CADASIL and disorders of consciousness

Anti-Notch3 immunotherapy, subclinical command following, and small fibre neuropathy. All topics...

Making sense of exercise in schizophrenia - No sweat!

Clinicians are well aware that cardiorespiratory fitness and cognition are related in schizophrenia...

Taper or maintain antipsychotics in schizophrenia?

Taper or maintain? This is a central dilemma surrounding use of antipsychotic medication in...

The neurobiology of conversion to psychosis – emerging findings from the SHARP study

The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to...

Congress highlights

What is the role of inflammation in the pathophysiology of mood disorders?

Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology...

Congress highlights

A public invitation to view and comment on pre-final APA schizophrenia guideline statements

Many guidelines exist worldwide on how best to manage psychiatric illnesses, but we never see two...

Congress highlights

Adherence in the real world

Non-adherence and lack of engagement commonly mean that patients with serious mental illnesses may...

Depression, Schizophrenia

Congress highlights

Lifestyle, the gut, and mental health

Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of...

Congress highlights

Neuroimaging, antipsychotics and registries – functional capacity

Neuroimaging studies of response to antipsychotic therapies and glutamate levels in first-episode...

Congress highlights

Enhancing neuroimaging genetics – What do we really see?

Enhancing neuroimaging genetics through meta-analysis (ENIGMA) does exactly what its expanded...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Ireland Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Portugal
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Portugal click here.

Continue to verification page Login with email

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

Accept

Decline